ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

ClinicalTrials.gov ID: NCT00647270

Public ClinicalTrials.gov record NCT00647270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind,Placebo-controlled Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Study identification

NCT ID
NCT00647270
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • adalimumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Mar 31, 2009
Completion
Mar 31, 2009
Last update posted
Apr 10, 2011

2007 – 2009

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Tuscaloosa Alabama 35406
Not listed Paradise Valley Arizona 85253
Not listed Hemet California 92543
Not listed Long Beach California 90806
Not listed Santa Monica California 90404
Not listed Torrance California 90505
Not listed Victorville California 92395
Not listed West Hills California 91307
Not listed Wheat Ridge Colorado 80033
Not listed Aventura Florida 33180
Not listed Orange Park Florida 32073
Not listed Palm Harbor Florida 34684
Not listed Sarasota Florida 34239
Not listed Tampa Florida 33614
Not listed Vero Beach Florida 32960
Not listed Atlanta Georgia 30342
Not listed Chicago Illinois 60612
Not listed Moline Illinois 61201
Not listed Springfield Illinois 62704
Not listed Wichita Kansas 67203
Not listed Lexington Kentucky 40515
Not listed Covington Louisiana 70433
Not listed Brighton Michigan 48116
Not listed Passaic New Jersey 07055
Not listed Smithtown New York 11787
Not listed The Bronx New York 10461
Not listed Ashville North Carolina 28801
Not listed Charlotte North Carolina 28209
Not listed Hickory North Carolina 28601
Not listed Monroe North Carolina 28112
Not listed Oklahoma City Oklahoma 73112
Not listed Bend Oregon 97701
Not listed Bethlehem Pennsylvania 18015
Not listed Duncansville Pennsylvania 16635
Not listed Philadelphia Pennsylvania 19152
Not listed West Reading Pennsylvania 19611
Not listed Charleston South Carolina 29406
Not listed Greenville South Carolina 29601
Not listed Jackson Tennessee 38305
Not listed Nashville Tennessee 37205
Not listed Dallas Texas 75235
Not listed Houston Texas 77034
Not listed Houston Texas 77074
Not listed San Antonio Texas 78217
Not listed Ogden Utah 84405
Not listed Olympia Washington 98502
Not listed Glendale Wisconsin 53217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00647270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2011 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00647270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →